menu Menu Search
What are you looking for? close
RCVS Registered: 7025700
Run by a qualified team of Vets
Tracked 24 Delivery only £4.29
Independent since 2008
30mg Librela Solution for Dogs - 2 Vials
View Larger

30mg Librela Solution for Dogs - 2 Vials

370964

£97.43 (inc. VAT)

30mg Librela for Dogs is a vet-prescribed monthly injection that targets Nerve Growth Factor (NGF) to relieve osteoarthritis pain in dogs, helping improve comfort, mobility and daily activity at home.

Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.

Osteoarthritis (Arthritis) is a long-term joint condition. In a healthy joint, smooth cartilage covers the ends of the bones and helps them glide with minimal friction. The joint also contains lubricating fluid and supportive tissues that keep movement stable. With osteoarthritis, cartilage gradually becomes damaged and less effective at cushioning. The joint lining can become inflamed, the joint can thicken, and movement can become painful and stiff. Dogs may avoid using the joint fully, which can lead to reduced muscle strength and poorer joint stability.

Osteoarthritis is common in older dogs, but it can develop at any age. Previous joint injury, repeated strain, and inherited joint conformation issues (such as hip or elbow dysplasia) can all contribute. Excess body weight is also important because it increases the load on painful joints and can worsen stiffness.

Librela 30mg contains bedinvetmab, which is a monoclonal antibody. Monoclonal antibodies are designed to target a specific molecule in the body. Bedinvetmab targets nerve growth factor (NGF), a signalling molecule involved in pain pathways. In osteoarthritis, NGF can contribute to ongoing pain by increasing the sensitivity of nerves in and around affected joints.

Because osteoarthritis is ongoing, Librela is usually repeated every month to help maintain consistent pain control. Your vet may suggest tracking changes in your dog’s daily activity and comfort, because gradual improvements can be easier to spot when you look back over a few weeks. If your dog’s mobility suddenly worsens, if they show new pain, or if you notice any change that concerns you, you should contact your veterinary practice for advice.

Product Features

add remove
  • Pack Size: - Pack of 2
  • Target Animal: - Dog (Canine)
  • Related Condition: - Osteoarthritis in Dogs
  • Pet Prescription Required?: - Yes
  • Active Ingredient: - Bedinvetmab
  • Product Name: - Librela solution for injection for dogs

More Information

add remove

Description

30mg Librela for Dogs is a veterinary medicine used to help control pain associated with osteoarthritis. It is supplied as an injectable solution. The 30mg strength is one of several vial sizes that helps your vet select an accurate dose based on your dog's body weight. Librela is usually given as a once-monthly injection by a veterinary professional as part of a wider plan to support comfort and mobility.

Dogs often show joint pain as changes in movement or behaviour rather than obvious yelping. Stiffness after rest is common, especially first thing in the morning. Limping may be worse after exercise, or a dog may simply become slower and less keen to play. Some dogs hesitate before jumping into the car, climbing stairs, or getting on furniture. Others seem quieter than usual, lick at a sore area, or become less tolerant of being touched around the hips, knees, elbows, or back end.

A vet will usually diagnose osteoarthritis by combining the history, a physical examination, and sometimes imaging such as X-rays. The aim of treatment is to reduce pain, support daily movement, and slow the cycle of stiffness and muscle loss as much as possible.

Bedinvetmab binds to NGF and helps prevent it from attaching to receptors on nerve cells. By reducing this pain signal, Librela can help decrease osteoarthritis-related pain and improve a dog’s comfort and willingness to move. Librela is intended to control pain. It does not rebuild cartilage or reverse existing joint changes, so it works best alongside appropriate lifestyle and mobility support.

Dogs can respond differently to osteoarthritis pain control. Some dogs show improved comfort within the first week after an injection, while others improve more gradually over several weeks. You may notice that your dog gets up more easily, walks more freely, or is more willing to use stairs and jump. In some dogs, early improvements are subtle, such as settling more comfortably, changing position less often, or seeming less stiff after rest.

Pain control is only one part of arthritis management. Weight management can make a large difference, because even small reductions in excess weight can reduce stress on joints. Regular, controlled exercise often helps maintain joint movement and muscle strength. Many dogs do better with shorter, more frequent walks rather than a single long walk.

Simple home changes can reduce strain and improve confidence. Non-slip mats can help on hard floors. A ramp or step can reduce repeated jumping into the car or onto furniture. A supportive bed in a warm, draught-free area can ease overnight stiffness. Depending on your dog’s needs, your vet may also recommend physiotherapy, hydrotherapy, or a joint supplement.

Librela is a prescription veterinary medicine and should be used under veterinary direction. It is an injectable product and is normally administered by a veterinary professional. Always follow your vet’s guidance about dosing intervals and any other medicines or supplements your dog may be taking. Do not start, stop, or combine pain treatments without professional advice.